ICD-10-CM Billable Code

I70.598

Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity

Clinical Classification Guidelines

Medical Intelligence & Overview

This condition refers to the buildup of fatty deposits, known as plaque, within the arteries of the extremities (arms or legs) where a bypass surgery has been performed using biological grafts that are not derived from the patient's own tissues. Such atherosclerosis can impair blood flow, potentially leading to complications such as pain, ulcers, or tissue loss. Recognizing this specific form of artery disease helps in proper management and prevention of further vascular issues.

Causes & Symptoms

Clinical Causes: Progressive buildup of cholesterol and other substances within the arterial walls Degeneration or wear and tear of biological grafts over time Chronic inflammation at the site of the graft Risk factors common to atherosclerosis, including high cholesterol, smoking, diabetes, high blood pressure, and obesity Poor blood flow dynamics around the graft area that promote plaque formation

Key Symptoms: Intermittent claudication (leg or arm pain during activity that subsides with rest) Coldness or numbness in the affected limb Changes in skin color or temperature Presence of non-healing wounds or ulcers Weak or absent pulse distal to the graft site Tissue or gangrene in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis often involves a combination of clinical examination and imaging studies. Tests used include:

Treatment Protocols: Managing this type of atherosclerosis involves several strategies aimed at restoring and maintaining blood flow:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is I70.598 a billable ICD-10 code?
Yes, I70.598 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report I70.598?
Clinical documentation must specify the nature of Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity and any associated comorbidities for accurate reporting.

Cite this Clinical Reference